Cargando…

Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?

Background: Our previous studies of human breast and prostate cancer have shown that aberrant immune cell infiltration is associated with focal tumor capsule disruption and tumor cell budding that facilitate invasion and metastasis. Our current study attempted to determine whether aberrant immune ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Bin, Mason, Jeffrey, Jewett, Anahid, Liu, Min-ling, Chen, Wen, Qian, Jun, Ding, Yijiang, Ding, Shuqing, Ni, Min, Zhang, Xichen, Man, Yan-gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607233/
https://www.ncbi.nlm.nih.gov/pubmed/23532368
http://dx.doi.org/10.7150/ijms.5798
_version_ 1782264093777854464
author Jiang, Bin
Mason, Jeffrey
Jewett, Anahid
Liu, Min-ling
Chen, Wen
Qian, Jun
Ding, Yijiang
Ding, Shuqing
Ni, Min
Zhang, Xichen
Man, Yan-gao
author_facet Jiang, Bin
Mason, Jeffrey
Jewett, Anahid
Liu, Min-ling
Chen, Wen
Qian, Jun
Ding, Yijiang
Ding, Shuqing
Ni, Min
Zhang, Xichen
Man, Yan-gao
author_sort Jiang, Bin
collection PubMed
description Background: Our previous studies of human breast and prostate cancer have shown that aberrant immune cell infiltration is associated with focal tumor capsule disruption and tumor cell budding that facilitate invasion and metastasis. Our current study attempted to determine whether aberrant immune cell infiltration would have similar impact on colorectal cancer (CRC). Materials and Methods: Tissue sections from 100 patients with primary CRC were assessed for the frequencies of focal basement membrane (BM) disruption, muscularis mucosa (MM) fragmentation, and tumor cell dissemination in epithelial structures adjacent and distal to infiltrating lymphoid aggregates using a panel of biomarkers and quantitative digital imaging. Results: Our study revealed: (1) epithelial structures adjacent to lymphoid follicles or aggregates had a significantly higher (p<0.001) frequency of focally disrupted BM, dissociated epithelial cells in the stroma, disseminated epithelial cells within lymphatic ducts or blood vessels, and fragmented MM than their distal counterparts, (2) a majority of dissociated epithelial cells within the stroma or vascular structures were immediately subjacent to or physically associated with infiltrating immune cells, (3) the junctions of pre-invasive and invasive lesions were almost exclusively located at sites adjacent to lymphoid follicles or aggregates, (4) infiltrating immune cells were preferentially associated with epithelial capsules that show distinct degenerative alterations, and (5) infiltrating immune cells appeared to facilitate tumor stem cell proliferation, budding, and dissemination. Conclusions: Aberrant immune cell infiltration may have the same destructive impact on the capsule of all epithelium-derived tumors. This, in turn, may selectively favor the proliferation of tumor stem or progenitor cells overlying these focal disruptions. These proliferating epithelial tumor cells subsequently disseminate from the focal disruption leading to tumor invasion and metastasis.
format Online
Article
Text
id pubmed-3607233
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-36072332013-03-25 Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression? Jiang, Bin Mason, Jeffrey Jewett, Anahid Liu, Min-ling Chen, Wen Qian, Jun Ding, Yijiang Ding, Shuqing Ni, Min Zhang, Xichen Man, Yan-gao Int J Med Sci Research Paper Background: Our previous studies of human breast and prostate cancer have shown that aberrant immune cell infiltration is associated with focal tumor capsule disruption and tumor cell budding that facilitate invasion and metastasis. Our current study attempted to determine whether aberrant immune cell infiltration would have similar impact on colorectal cancer (CRC). Materials and Methods: Tissue sections from 100 patients with primary CRC were assessed for the frequencies of focal basement membrane (BM) disruption, muscularis mucosa (MM) fragmentation, and tumor cell dissemination in epithelial structures adjacent and distal to infiltrating lymphoid aggregates using a panel of biomarkers and quantitative digital imaging. Results: Our study revealed: (1) epithelial structures adjacent to lymphoid follicles or aggregates had a significantly higher (p<0.001) frequency of focally disrupted BM, dissociated epithelial cells in the stroma, disseminated epithelial cells within lymphatic ducts or blood vessels, and fragmented MM than their distal counterparts, (2) a majority of dissociated epithelial cells within the stroma or vascular structures were immediately subjacent to or physically associated with infiltrating immune cells, (3) the junctions of pre-invasive and invasive lesions were almost exclusively located at sites adjacent to lymphoid follicles or aggregates, (4) infiltrating immune cells were preferentially associated with epithelial capsules that show distinct degenerative alterations, and (5) infiltrating immune cells appeared to facilitate tumor stem cell proliferation, budding, and dissemination. Conclusions: Aberrant immune cell infiltration may have the same destructive impact on the capsule of all epithelium-derived tumors. This, in turn, may selectively favor the proliferation of tumor stem or progenitor cells overlying these focal disruptions. These proliferating epithelial tumor cells subsequently disseminate from the focal disruption leading to tumor invasion and metastasis. Ivyspring International Publisher 2013-03-05 /pmc/articles/PMC3607233/ /pubmed/23532368 http://dx.doi.org/10.7150/ijms.5798 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.
spellingShingle Research Paper
Jiang, Bin
Mason, Jeffrey
Jewett, Anahid
Liu, Min-ling
Chen, Wen
Qian, Jun
Ding, Yijiang
Ding, Shuqing
Ni, Min
Zhang, Xichen
Man, Yan-gao
Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
title Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
title_full Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
title_fullStr Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
title_full_unstemmed Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
title_short Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
title_sort tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607233/
https://www.ncbi.nlm.nih.gov/pubmed/23532368
http://dx.doi.org/10.7150/ijms.5798
work_keys_str_mv AT jiangbin tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT masonjeffrey tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT jewettanahid tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT liuminling tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT chenwen tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT qianjun tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT dingyijiang tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT dingshuqing tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT nimin tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT zhangxichen tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression
AT manyangao tumorinfiltratingimmunecellstriggersfortumorcapsuledisruptionandtumorprogression